Oragen
From EverybodyWiki Bios & Wiki
Oragen drugs are highly experimental nucleic acid technologies related to Ampligen, developed by HEMISPHERx Biopharma, Inc. It is hoped they will have antiviral effects. They are undergoing pre-clinical (in-vitro) trials.[1]
Mechanism of action[edit]
It is believed that Oragen regulates the RNase L pathway and may also have effects specifically against the HIV virus.
References[edit]
- ↑ CARTER, WILLIAM A.; SUHADOLNIK, ROBERT J.; MÜLLER, WERNER E. G.; KORBA, BRENT E.; HUBBELL, HOWARD R.; GARCIA, GABRIEL; STRAYER, DAVID R. (1 June 1993). "Specific RNA Drug Therapy of Hepatitis Viruses". Annals of the New York Academy of Sciences. 685 (1 Immunomodulat): 758–761. doi:10.1111/j.1749-6632.1993.tb35938.x. Retrieved 15 July 2018.
External links[edit]
 | This immunology article is a stub. You can help EverybodyWiki by expanding it. |
This article "Oragen" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Oragen. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
